LINC02106

Across TCGA pan-cancer cohorts, LINC02106 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of LINC02106’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where LINC02106 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC02106 is over-expressed in tumor, although a few such as STAD and THCA show the opposite, repressed pattern.

STAD, THCA, and BRCA are the cancer types where LINC02106 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC02106 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	−1.232	<.001	9	view →
THCA	All	II,III,IV	−0.200	<.001	9	view →
BRCA	Female	All	−0.036	.004	5	view →
COAD	Female	II,III,IV	−0.235	.015	4	view →
HNSC	Male	II,III,IV	−0.062	.031	4	view →
PRAD	All	All	−0.604	<.001	2	view →
KIRC	All	All	−0.013	.005	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

LINC02106–STAD

Open the STAD breakdown →